ALKS
Price
$26.13
Change
-$0.40 (-1.51%)
Updated
Jul 25 closing price
Capitalization
4.55B
2 days until earnings call
PAHC
Price
$29.18
Change
-$0.26 (-0.88%)
Updated
Jul 25 closing price
Capitalization
523.71M
31 days until earnings call
Interact to see
Advertisement

ALKS vs PAHC

Header iconALKS vs PAHC Comparison
Open Charts ALKS vs PAHCBanner chart's image
Alkermes
Price$26.13
Change-$0.40 (-1.51%)
Volume$1.69M
Capitalization4.55B
Phibro Animal Health
Price$29.18
Change-$0.26 (-0.88%)
Volume$199.51K
Capitalization523.71M
ALKS vs PAHC Comparison Chart in %
Loading...
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALKS vs. PAHC commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALKS is a Hold and PAHC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (ALKS: $26.13 vs. PAHC: $29.18)
Brand notoriety: ALKS and PAHC are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALKS: 96% vs. PAHC: 70%
Market capitalization -- ALKS: $4.55B vs. PAHC: $523.71M
ALKS [@Pharmaceuticals: Other] is valued at $4.55B. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALKS’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 1 green FA rating(s).

  • ALKS’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 1 green, 4 red.
According to our system of comparison, ALKS is a better buy in the long-term than PAHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALKS’s TA Score shows that 4 TA indicator(s) are bullish while PAHC’s TA Score has 4 bullish TA indicator(s).

  • ALKS’s TA Score: 4 bullish, 6 bearish.
  • PAHC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PAHC is a better buy in the short-term than ALKS.

Price Growth

ALKS (@Pharmaceuticals: Other) experienced а -10.57% price change this week, while PAHC (@Pharmaceuticals: Other) price change was -0.78% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.51%. For the same industry, the average monthly price growth was +11.90%, and the average quarterly price growth was +74.65%.

Reported Earning Dates

ALKS is expected to report earnings on Jul 29, 2025.

PAHC is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.51% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALKS($4.55B) has a higher market cap than PAHC($524M). PAHC has higher P/E ratio than ALKS: PAHC (34.11) vs ALKS (8.90). PAHC YTD gains are higher at: 40.341 vs. ALKS (-9.145). ALKS has higher annual earnings (EBITDA): 519M vs. PAHC (83.7M). ALKS has more cash in the bank: 773M vs. PAHC (92.5M). ALKS has less debt than PAHC: ALKS (372M) vs PAHC (513M). ALKS has higher revenues than PAHC: ALKS (1.66B) vs PAHC (982M).
ALKSPAHCALKS / PAHC
Capitalization4.55B524M869%
EBITDA519M83.7M620%
Gain YTD-9.14540.341-23%
P/E Ratio8.9034.1126%
Revenue1.66B982M169%
Total Cash773M92.5M836%
Total Debt372M513M73%
FUNDAMENTALS RATINGS
ALKS vs PAHC: Fundamental Ratings
ALKS
PAHC
OUTLOOK RATING
1..100
5776
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
4770
SMR RATING
1..100
3862
PRICE GROWTH RATING
1..100
8138
P/E GROWTH RATING
1..100
5390
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PAHC's Valuation (30) in the Pharmaceuticals Major industry is significantly better than the same rating for ALKS (99) in the Biotechnology industry. This means that PAHC’s stock grew significantly faster than ALKS’s over the last 12 months.

ALKS's Profit vs Risk Rating (47) in the Biotechnology industry is in the same range as PAHC (70) in the Pharmaceuticals Major industry. This means that ALKS’s stock grew similarly to PAHC’s over the last 12 months.

ALKS's SMR Rating (38) in the Biotechnology industry is in the same range as PAHC (62) in the Pharmaceuticals Major industry. This means that ALKS’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's Price Growth Rating (38) in the Pharmaceuticals Major industry is somewhat better than the same rating for ALKS (81) in the Biotechnology industry. This means that PAHC’s stock grew somewhat faster than ALKS’s over the last 12 months.

ALKS's P/E Growth Rating (53) in the Biotechnology industry is somewhat better than the same rating for PAHC (90) in the Pharmaceuticals Major industry. This means that ALKS’s stock grew somewhat faster than PAHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALKSPAHC
RSI
ODDS (%)
Bullish Trend 3 days ago
68%
Bearish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
62%
Bullish Trend 3 days ago
73%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 5 days ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
68%
Aroon
ODDS (%)
Bearish Trend 3 days ago
57%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ALKS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMCRX34.000.30
+0.89%
Lord Abbett Mid Cap Stock R3
ECERX21.260.10
+0.47%
Eaton Vance Stock C
CAFEX42.590.16
+0.38%
American Funds AMCAP 529E
NARCX66.74-0.16
-0.24%
Voya Multi-Manager International Sm Cp C
JDIAX53.24-0.21
-0.39%
Janus Henderson Overseas A

ALKS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALKS has been loosely correlated with COLL. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ALKS jumps, then COLL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALKS
1D Price
Change %
ALKS100%
-1.51%
COLL - ALKS
36%
Loosely correlated
-1.03%
ESPR - ALKS
35%
Loosely correlated
+1.34%
AMRX - ALKS
34%
Loosely correlated
+0.75%
PRGO - ALKS
34%
Loosely correlated
+1.14%
VTRS - ALKS
32%
Poorly correlated
+0.64%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
-0.88%
PBH - PAHC
48%
Loosely correlated
+0.79%
AMRX - PAHC
47%
Loosely correlated
+0.75%
ZTS - PAHC
41%
Loosely correlated
-0.46%
ELAN - PAHC
40%
Loosely correlated
+1.57%
VTRS - PAHC
38%
Loosely correlated
+0.64%
More